BioFocus and Almac collaborate to offer fluorescent lifetime assaysBioFocus announced today that it has entered into collaboration with Almac allowing BioFocus customers with compound screening and profiling requirements to access Almac’s FLEXYTETM fluorescence lifetime (FLT) assays. Integrating the assay technology allows BioFocus to offer an FLT platform that will complement its current target class capabilities, provide access to previously inaccessible epigenetic targets and offer alternative approaches to fragment-based screens and kinetic profiling.
“Being able to incorporate FLT assays in our service offering enables BioFocus to provide clients with an approach to screening and profiling that will unlock significant potential within their drug discovery efforts” commented Dr Kate Hilyard, VP Biological Sciences, BioFocus.
”We are delighted that BioFocus has chosen to add our FLEXYTETM technology to their service offering. We feel that this will allow a broad range of drug discovery groups access to the power of FLT” said Dr Stephen Barr, President and Managing Director of Almac Sciences.
BioFocus aims to expand its partners’ drug pipelines by accelerating the gene-to-drug candidate discovery process. This is achieved through a comprehensive discovery platform, which includes target discovery in human primary cells, focused as well as diverse compound libraries, in vitro and cell-based screening, structural biology, medicinal chemistry, ADME/PK services, supported by unique chemogenomic and informatics tools, and compound library acquisition, storage and distribution services. As a service division of Galapagos, BioFocus has over 250 employees in four countries worldwide. More information at biofocus.com.
About Almac Group
Almac is a financially stable, privately owned organisation with over 30 years’ experience. It provides integrated development solutions to over 600 customers worldwide including all the world leaders in the pharmaceutical and biotechnology sectors. Their services include R&D, translational genomic services; API manufacture; formulation development; clinical trial supply and technology (IVRS/IWRS/ePRO) and commercial-scale manufacture.
For more information about the Almac Group, please visit www.almacgroup.com or e-mail firstname.lastname@example.org.
Office 3 Universal Marina | Crableck Lane | Sarisbury Green | Southampton | SO31 7AL
Tel: +44 1799 533 500
Alto Marketing Limited:
Tel: +44 1489 557 672
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BioFocus and Almac collaborate to offer fluorescent lifetime assays here
News-ID: 168560 • Views: 1601
More Releases from BioFocus
Argenta and BioFocus announce two-year extension of drug discovery collaboration …
Galapagos NV (Euronext: GLPG) announced today that its service division Argenta has extended its integrated contract drug discovery agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY). Total potential value of the contract extension is up to £21.5 million (€23.4 million). This is the third such extension since the agreement was announced in December 2005. The agreement covers a number of drug discovery
BioFocus and InterMed Discovery announce Marketing Collaboration
BioFocus, an integrated drug discovery service partner, and InterMed Discovery GmbH (IMD), a natural product lead-discovery company, today announced a marketing collaboration to offer enhanced natural product discovery to the pharmaceutical, animal health, and agrochemical industries. No financial details were disclosed. Under the terms of the collaboration, IMD will make its natural product screening libraries available and provide follow-on services to BioFocus. BioFocus will then incorporate these as part of
BioFocus enters collaboration with Michael J. Fox Foundation
BioFocus announced today that it has signed a collaboration agreement with The Michael J. Fox Foundation for Parkinson’s Research, a not-for-profit organization focused on developing therapies for Parkinson’s disease. Under the agreement, BioFocus will perform fragment-based screening, assay development and hit-finding programs, to identify compounds that have the basis for a novel Parkinson’s disease diagnostic test. “We are delighted to have the opportunity to support The Michael J.
BioFocus extends collaboration with Usher III Initiative
BioFocus announced today that it has expanded a collaboration with the Usher III Initiative, Inc., a non-profit organization focused on developing treatments for Usher syndrome type III, a rare genetic disorder that causes the loss of hearing and vision. BioFocus and the Usher III Initiative began their collaboration in July 2010 with BioFocus performing an integrated drug discovery program encompassing medicinal chemistry, ADME and biological sciences, aiming at a
More Releases for Almac
Precision Medicine Market to Witness Huge Growth by 2026 | Almac, GE healthcare, …
Latest Study on Industrial Growth of Europe Precision Medicine Market 2021-2027. A detailed study accumulated to offer Latest insights about acute features of the Precision Medicine market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and
Healthcare Analytical Testing Services Market is Going To Boom | Exova, Almac, E …
A Latest intelligence report published by AMA Research with title "Healthcare Analytical Testing Services Market Outlook to 2026. A detailed study accumulated to offer Latest insights about acute features of the Global Healthcare Analytical Testing Services Market. This report provides a detailed overview of key factors in the Healthcare Analytical Testing Services Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. A thorough
Bioanalytical Testing Services Market Worth Observing Strong Growth by Almac Gro …
Bioanalytical Testing Services Market report provides information about the industry, including valuable Analysis and Detailed study. This research study explores the Global Bioanalytical Testing Services Market in detail such as industry chain structures, raw material suppliers, with manufacturing. The Bioanalytical Testing Services market examines the primary segments of the market. This intelligent study provides historical data from forecast. With a devotion and commitment of supreme level of resilience and integrated
Global Clinical Trial Supplies Market 2020 Business Strategies – KLIFO A/S, Pa …
The Zion Market Research added a new report “Clinical Trial Supplies Market: by Product/ Services (Manufacturing, Packaging and Labeling, and Storage and Distribution), by Application (Oncology, CNS, Cardiovascular, Infectious Diseases, Metabolic Disorders, and Others), by Phase (Phase I, Phase II, Phase III, & Others), and by End User (Contract Research Organizations, Pharmaceutical and Biotechnology Companies, Research Institutes, & Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024” in
Precision Medicine Market: Good Value & Room to Grow Ahead Seen | Novartis, Abbo …
The latest 132+ page survey report on Global Precision Medicine Market is released by HTF MI covering various players of the industry selected from global geographies like North America, Europe, China, Japan, Southeast Asia, India & Central & South America. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunity available and would trend in Precision Medicine market.
Prostate Cancer Screening Market Overview and Forecast Report 2019| Abbott Labor …
The report on the global Prostate Cancer Screening market is comprehensively prepared with main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It sheds light on key production, revenue, and consumption trends so that players could improve their sales and growth in the Global Prostate Cancer Screening Market. It offers a detailed analysis of the competition and leading companies of the global